Detalhe da pesquisa
1.
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias.
Blood
; 118(18): 4817-28, 2011 Nov 03.
Artigo
Inglês
| MEDLINE | ID: mdl-21849486
2.
Depletion of high-content CD14+ cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing.
Mol Ther Methods Clin Dev
; 22: 377-387, 2021 Sep 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34514029
3.
Multifactorial optimization of gammaretroviral gene transfer into human T lymphocytes for clinical application.
Hum Gene Ther
; 18(12): 1253-60, 2007 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-18052719
4.
Targeted elimination of prostate cancer by genetically directed human T lymphocytes.
Cancer Res
; 65(19): 9080-8, 2005 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-16204083
5.
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.
Sci Transl Med
; 6(224): 224ra25, 2014 Feb 19.
Artigo
Inglês
| MEDLINE | ID: mdl-24553386
6.
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia.
Sci Transl Med
; 5(177): 177ra38, 2013 Mar 20.
Artigo
Inglês
| MEDLINE | ID: mdl-23515080
7.
Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy.
J Immunother
; 32(2): 169-80, 2009.
Artigo
Inglês
| MEDLINE | ID: mdl-19238016